Direktor/Vorstandsmitglied bei Arthritis Innovation Corp.
Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
---|---|---|---|---|
Wayne Marshall | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Mark Krembil | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Nizar Mahomed | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Glenys Foster-Roberts | M | - |
Arthritis Innovation Corp.
![]() Arthritis Innovation Corp. Medical/Nursing ServicesHealth Services Arthritis Innovation Corp. operates as a clinical-stage pharmaceutical company addressing unmet needs in Orthopedic surgery and Arthritis management. Its first drug in Phase 2 clinical testing uses sustained local delivery of an NSAID after total knee replacement to manage pain and inflammation as an alternative to oral NSAIDs or narcotics. The company was founded in 2013 and is headquartered in Toronto, Canada. | - |
Beziehungen zu mehreren Unternehmen
Land | Beziehungen | % des Gesamten |
---|---|---|
Kanada | 4 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen